{
    "code": "02025729",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025729",
    "time": "2021-10-15 07:27:59",
    "許可證字號": "衛署藥輸字第025729號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/06\/14",
    "發證日期": "101\/06\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202572904",
    "中文品名": "氣舒痰&#174;液2毫克\/毫升(印尼廠)",
    "英文品名": "Bisolvon &#174; Solution 2mg\/ml",
    "適應症": "袪痰。",
    "劑型": "170內服液劑",
    "包裝": "4-4000毫升棕色玻璃瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BROMHEXINE HCL",
    "限制項目": "02輸　入",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "": "INDONESIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4800000310",
            "成分名稱": "BROMHEXINE HCL",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Bisolvon solution_TWPI_C_CCDS v1_final clean-109-10-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025729&Seq=008&Type=9"
        },
        {
            "title": "P018441-002 LA BISOLVON,LIQUID 10MG 5ML 50ML-BI(1060314)-106-05-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025729&Seq=004&Type=8"
        },
        {
            "title": "P018439-001 FB BISOLVON,LIQUID 10MG 5ML 50ML_BI(1060323)-106-05-10.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025729&Seq=003&Type=8"
        }
    ]
}